Vyv, a female-founded and led health-tech industry business in antimicrobial light emitting diode (LED) technology, has announced recent independent test results confirming efficacy of its antimicrobial light technology (405 nm) for killing viruses. Numerous studies have proven the effectiveness of Vyv’s visible light against bacteria, mold, fungi, and yeast. This recent study has confirmed, through an independent third-party lab, that Vyv’s antimicrobial LED products are also effective against non-enveloped viruses, which are the most difficult class of virus to kill.

Additionally, a recent separate third-party study completed by the Icahn School of Medicine at Mount Sinai also demonstrated efficacy results using ranges of light in the 400–420 nm range on inactivating enveloped viruses. With Vyv’s commitment to ongoing research and development advancements of a myriad of new products for healthier spaces, the company will continue to expand its virus testing in the coming months.

Since its inception less than 10 years ago, Vyv’s growth has been fueled by its quest to develop smarter ways to better control microbial levels in the environments we live and work in—eliminating Listeria from food processing facilities, inactivating viruses, creating cleaner elevator buttons by lighting them from behind to simply removing mold and mildew from your bathroom shower—all being led by the development of Vyv’s proprietary UV-free antimicrobial LED technology.

Vyv holds patents for the world’s first single white light antimicrobial diode. This has driven new and exciting applications for applying Vyv’s violet and white antimicrobial lights to address the most challenging spaces and places. In all, Vyv holds 21 patents with 29 patents pending.

Vyv | https://vyv.tech/